Hit enter to search or ESC to close
ERA4TBERA4TBERA4TB
  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
Category

News

News

TB Alliance Announces First Patient Dosed with TBAJ-587 in Phase 1 Study

TB Alliance announced that on December 1, 2020, the first dose was administered to a…
IT Synapse
IT SynapseDecember 17, 2020
News

ERA4TB at the Union World Conference

From 22 to 24 October took place the 51st Union World conference on lung health.…
IT Synapse
IT SynapseNovember 30, 2020
News

The potential impact of the Covid-19 response on tuberculosis in high-burden countries: a modelling analysis

Developed by Stop TB Partnership in collaboration with Imperial College, Avenir Health, Johns Hopkins University…
admin
adminMay 20, 2020
Previous 1 2 3

Recent Posts

  • ERA4TB to host public key-note speeches at annual meeting
  • Celebrating women in TB research
  • ERA4TB researchers win prestigious award for innovation
  • ERA4TB researchers participate in the European Researcher’s Night
  • Sustainable funding required to protect current early phase antibiotics Research & Development for Tuberculosis and beyond

Categories

  • Event
  • News
  • Press
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Events
  • Press
  • Newsletter
  • Video Library
  • Blog
Result
  • Publications
  • Deliverables

© 2025 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.